PRIME PEOPLE | DOUGLAS INGRAM |
DOUGLAS INGRAM ALLERGAN
In the post-PIP era, the medical aesthetics industry can expect to be dogged by issues of trust and quality. Rosalind Hill speaks to Douglas Ingram about how Allergan plans to address these questions head-on
I 62 ❚
N THE POST-PIP AESTHETIC world, reaction to the scandal has varied. Some have called for stricter regulation and a ban of advertising to consumers; some have withdrawn from the
potential risks that can accompany innovative practice; and others have addressed the situation directly by reinforcing the concept of quality within the industry as a whole, as well as continuing to drive high standards of practice. 'In these situations it's always good to
step back and reflect on ways to bolster the process,' says Douglas Ingram, President, Europe, Africa and Middle East (EAME), Allergan.
'There are certainly some things we
can do, but I think it is an error to believe that additional, very draconian regulations will ultimately solve the next PIP.'
This is something that Allergan hopes
to address through their new 'Quality is Key' Campaign. Allergan believes that the real issue arising from the PIP crisis is to provide physicians with the concrete information needed to answer the questions that patients might have; therefore creating intelligent and thoughtful consultations so that patients can make informed decisions on their treatment. 'I think that giving doctors the tools to decide which products have made
April/May 2012 |
prime-journal.com
themselves worthy of trust and which have the right quality profile ® to give information and the tools needed to have that conversation with patients ® should raise the bar more than any regulations,' explains Mr Ingram.
Raising the bar It is often the case that the patient will not know which questions to ask his/her physician, and leave the consultation with their fears and doubts intact; therefore, as an unbranded venture, the Quality is Key Campaign aims to equip consumers with the right questions to ask when considering medical aesthetic treatments, and enable them to get the highest quality consultation. The
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84